# Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis

> **NCT00689520** · PHASE4 · COMPLETED · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 241 (actual)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** tinzaparin
- **DRUG:** acenocoumarol

## Key facts

- **NCT ID:** NCT00689520
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2008-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00689520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00689520, "Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00689520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*